Drug resistance rates of Mycobacterium tuberculosis at a private referral center in Korea

Journal of Korean Medical Science

Volumn 22, Issue 4, 2007, Pages 677-681

  Jae, Chol Choi ^a   Song, Yong Lim ^a,c   Gee, Young Suh ^a   Man, Pyo Chung ^a   Kim, Hojoong ^a   On, Jung Kwon ^a   Nam, Yong Lee ^a   Young, Kil Park ^b   Gil, Han Bai ^b   Koh, Won Jung ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Korean Institute of Tuberculosis   (South Korea)

^c School of Medicine   (South Korea)

Author keywords

Drug resistance; Isoniazid; Korea; Mycobacterium tuberculosis; Rifampin

Indexed keywords

EID: 34548563732     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2007.22.4.677     Document Type: Article

References (29)

1. Espinal MA, Kim SJ, Suarez PG, Kam KM, Khomenko AG, Migliori GB, Baez J, Kochi A, Dye C, Raviglione MC. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA 2000; 283: 2537-45.
2. Colebunders R, Apers L, Shamputa IC. Treatment of multidrug-resistant tuberculosis. Lancet 2004; 363: 1240.
3. Timperi R, Han LL, Sloutsky A, Becerra MC, Nardell EA, Salazar JJ, Smith-Fawzi MC. Drug resistance profiles of Mycobacterium tuberculosis isolates: five years' experience and insight into treatment strategies for MDR-TB in Lima, Peru. Int J Tuberc Lung Dis 2005; 9: 175-80.
4. Ferrara G, Richeldi L, Bugiani M, Cirillo D, Besozzi G, Nutini S, Casali L, Fiorentini F, Codecasa LR, Migliori GB. Management of multidrug-resistant tuberculosis in Italy. Int J Tuberc Lung Dis 2005; 9: 507-13.
5. Torun T, Gungor G, Ozmen I, Bolukbasi Y, Maden E, Bicakci B, Atac G, Sevim T, Tahaoglu K. Side effects associated with the treatment of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2005; 9: 1373-7.
6. Kang YA, Choi YJ, Cho YJ, Lee SM, Yoo CG, Kim YW, Han SK, Shim YS, Yim JJ. Cost of treatment for multidrug-resistant tuberculosis in South Korea. Respirology 2006; 11: 793-8.
7. Korean Center for Disease Control and Prevention. Annual report on the notified tuberculosis patients in Korea (2005.1-2005.12). 2006.
8. Seung KJ, Bai GH, Kim SJ, Lew WJ, Park SK, Kim JY. The treatment of tuberculosis in South Korea. Int J Tuberc Lung Dis 2003; 7: 912-9.
9. Kim SJ, Bai GH, Hong YP. Drug-resistant tuberculosis in Korea, 1994. Int J Tuberc Lung Dis 1997; 1: 302-8.
10. Pablos-Mendez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, Cohn DL, Lambregts-van Weezenbeek CS, Kim SJ, Chaulet P, Nunn P. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 1998; 338: 1641-9.
11. Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A, Hoffner S, Rieder HL, Binkin N, Dye C, Williams R, Raviglione MC. Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 2001; 344: 1294-303.
12. Bai GH, Park YK, Choi YW, Bai JI, Kim HJ, Chang CL, Lee JK, Kim SJ. Trend of anti-tuberculosis drug resistance in Korea, 1994-2004. Int J Tuberc Lung Dis 2007; 11: 571-6.
13. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000; 161: 1376-95.
14. World Health Organization. Treatment of tuberculosis: guidelines for national programmes 2003.
15. World Health Organization. Report of the meeting of the WHO Global Task Force on XDR-TB. 2006.
16. Hong YP, Kim SJ, Lew WJ, Lee EK, Han YC. The seventh nationwide tuberculosis prevalence survey in Korea, 1995. Int J Tuberc Lung Dis 1998; 2: 27-36.
17. Kim JH, Kim JH, Jang TW, Jung MH. Drug-resistant pulmonary tuberculosis in Kosin Medical Center. Tuber Respir Dis 1995; 42: 831-7.
18. Kim SY, Jeong SS, Kim KW, Shin KS, Park SG, Kim AK, Cho HJ, Kim JO. Drug-resistant pulmonary tuberculosis in a tertiary referral hospital in Korea. Korean J Intern Med 1999; 14: 27-31.
19. Lee JH, Chang JH. Drug-resistant tuberculosis in a tertiary referral teaching hospital of Korea. Korean J Intern Med 2001; 16: 173-9.
20. Kim DK, Kim MO, Kim TH, Sohn JW, Yoon HJ, Shin DH, Park SS. The prevalence and risk factors of drug resistance pulmonary tuberculosis investigated at one university hospital in Seoul. Tuber Respir Dis 2005; 58: 243-7.
21. Centers for Disease Control and Prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs - worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006; 55: 301-5.
22. Arevalo M, Solera J, Cebrian D, Bartolome J, Robles P. Risk factors associated with drug-resistant Mycobacterium tuberculosis in Castilla-la-Mancha (Spain). Eur Respir J 1996; 9: 274-8.
23. Ruddy M, Balabanova Y, Graham C, Fedorin I, Malomanova N, Elisarova E, Kuznetznov S, Gusarova G, Zakharova S, Melentyev A, Krukova E, Golishevskaya V, Erokhin V, Dorozhkova I, Drobniewski F. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax 2005; 60: 130-5.
24. Faustini A, Hall AJ, Perucci CA. Risk factors for multi-drug resistant tuberculosis in Europe: a systematic review. Thorax 2006; 61: 158-63.
25. Djuretic T, Herbert J, Drobniewski F, Yates M, Smith EG, Magee JG, Williams R, Flanagan P, Watt B, Rayner A, Crowe M, Chadwick MV, Middleton AM, Watson JM. Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999. Thorax 2002; 57: 477-82.
26. Kordy FN, Al-Thawadi S, Alrajhi AA. Drug resistance patterns of Mycobacterium tuberculosis in Riyadh, Saudi Arabia. Int J Tuberc Lung Dis 2004; 8: 1007-11.
27. Harrow EM, Rangel JM, Arriega JM, Cohen I, Regil Ruiz MI, DeRiemer K, Small PM. Epidemiology and clinical consequences of drug-resistant tuberculosis in a Guatemalan hospital. Chest 1998; 113: 1452-8.
28. Sharma SK, Turaga KK, Balamurugan A, Saha PK, Pandey RM, Jain NK, Katoch VM, Mehra NK. Clinical and genetic risk factors for the development of multi-drug resistant tuberculosis in non-HIV infected patients at a tertiary care center in India: a case-control study. Infect Genet Evol 2003; 3: 183-8.
29. Espinal MA, Laserson K, Camacho M, Fusheng Z, Kim SJ, Tlali RE, Smith I, Suarez P, Antunes ML, George AG, Martin-Casabona N, Simelane P, Weyer K, Binkin N, Raviglione MC. Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis 2001; 5: 887-93.